Global Development Lead, Early Clinical Development, Internal Medicine

The Global Development Lead for Internal Medicine at Pfizer drives clinical research strategy for cardiometabolic diseases, translating pre-clinical observations into Phase 1/2 studies to demonstrate proof of concept. This role involves leading clinical development plans, ensuring medical and scientific excellence, managing regulatory submissions, and collaborating with cross-functional teams and external experts. The position serves as a pivotal interface between bench science and bedside trials, focusing on innovative study designs and ethical standards.